Immunovant (IMVT) CLO Christopher Van Tuyl Sells Shares

What Happened
Christopher Van Tuyl, Chief Legal Officer of Immunovant (IMVT), sold 2,846 shares on 2026-09-23 at a weighted average price of $36.36 per share, generating approximately $103,481. The sale was not a discretionary trade but a "sell to cover" to satisfy tax withholding related to RSUs that vested.

Key Details

• Transaction date: 2026-09-23; Form 4 filed: 2026-09-25 (timely filing).
• Shares sold: 2,846; weighted average price reported: $36.36; total value ≈ $103,481.
• Price range for the multiple trades: $36.35 – $36.66 (Reporting Person can provide per‑trade breakdown on request).
• Footnote F1: The shares come from RSUs originally granted 12/16/2024 (109,956 RSUs); 6,872 RSUs vested on 9/16/2026. The sale was mandated by the issuer’s election to satisfy tax withholding via "sell to cover."
• Footnote F2: Weighted average price; multiple executions within stated range.
• Shares owned after the transaction: not specified in the provided filing details.

Context
This was a tax‑related sell to cover RSU withholding rather than a discretionary sale that signals a change in insider sentiment. Such sell-to-cover transactions are common when restricted stock units vest and do not necessarily indicate confidence or concern about the company’s outlook.